arrow
E

Eva Corey

university of washington
H指数:65
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

tRNA dosage regulates lineage dependency and resistance in prostate cancer

tRNA剂量调控前列腺癌细胞谱系依赖性和耐药性

Nature
IF48.5
2026-10-070
OA
Evolution and heterogeneity of lethal metastatic bladder cancer subtypes

致死性转移性膀胱癌亚型的演化和异质性

Nature
IF48.5
2026-09-160
OAAI
Patient-derived models of prostate cancer: Capturing tumour complexity from initiation to metastasis

患者来源的前列腺癌模型:从起始到转移捕捉肿瘤复杂性

2026-08-010
OAAI
A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator

全基因组CRISPR筛选在人前列腺癌细胞中揭示了巨噬细胞介导的细胞杀伤的驱动因子,并将AR定位为肿瘤内源性免疫调节因子

2026-07-280
PRE
Disrupting the interaction between androgen receptor and its coregulator WDR77 delays the growth of treatment-resistant prostate cancer

破坏雄激素受体与其共调节因子WDR77之间的相互作用会延缓治疗抵抗性前列腺癌的生长

2025-09-090
OAAI
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancer

表观遗传谱分析鉴定了内分泌抵抗的标志物及转移性去势抵抗性前列腺癌的治疗选择

2025-07-020
OAAI
Alteration in expression and subcellular localization of the androgen receptor- regulated FAM111A protease is associated with emergence of castration resistant prostate cancer

雄激素受体调控的FAM111A蛋白酶的表达和亚细胞定位的改变与去势抵抗性前列腺癌的出现相关。

2025-05-290
PRE
Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants
2025-04-110
OAAI
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer

核因子I介导的染色质可及性增加驱动前列腺癌向雄激素受体剪接变异体依赖性转变

2025-01-011
OA
Castrate-resistant prostate cancer response to taxane is determined by an HNF1-dependent apoptosis resistance circuit

去势抵抗性前列腺癌对紫杉烷的反应由HNF1依赖的凋亡抵抗回路决定

2024-12-010
PRE
BCL2 expression is enriched in advanced prostate cancer with features of lineage plasticity
2024-09-170
OAAI
Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancer
2024-08-050
OAAI